By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Announcement: Melatonin’s safety paradox: effective sleep aid undermined by unregulated product quality

Announcement: Melatonin’s safety paradox: effective sleep aid undermined by unregulated product quality

GMJ
Last updated: 15/08/2026 01:29
By
Prof. Giorgi Pkhakadze
Share
0 Min Read
Pharmacy shelves with melatonin supplements showing variable packaging and dosages, illustrating lack of regulatory standardisation
Melatonin is clinically effective for sleep disorders, but unregulated supplement manufacturing in the US creates quality control gaps that undermine safety. Product variability, inconsistent dosing standards, and minimal FDA oversight expose consumers—especially children—to preventable harms despite the drug's proven efficacy. — Photo by Supliful - Supplements On Demand on Unsplash (Unsplash License)
SHARE
1 min read|44 words

Melatonin works—but unregulated US supplement manufacturing undermines its safety. Products often mislabeled, dosing varies wildly, and children are at risk. New reporting highlights why dietary supplement classification creates a quality crisis and what regulators must do.

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Announcement

📰 Read the full article: Melatonin’s safety paradox: effective sleep aid undermined by unregulated product quality →

Related reference
  • Melatonin · Ingredient
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Brain Energy Demands: Why Your Hardest Thinking Uses Only 5% More Fuel

The brain uses only 5% more energy during intensive thinking than at…

How Your Gut Absorbs Nutrients: A Section-by-Section Guide to Digestive Checkpoints

Nutrient absorption is not a single process but a carefully choreographed sequence…

How Vitamin D Becomes an Antimicrobial Weapon Inside Your Immune Cells

Macrophages actively convert vitamin D into cathelicidin, a potent antimicrobial peptide, when…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Medical conference presentation showing obesity drug development data

Next-Generation Triple Hormone Obesity Drugs Advance to Clinical Testing

By
Prof. Giorgi Pkhakadze
20/06/2026
Community health worker using mobile device for tuberculosis contact investigation in rural health setting

Digital Innovation Accelerates TB Contact Tracing in Resource-Limited Settings

By
Prof. Giorgi Pkhakadze
18/07/2026
Senior adult performing supervised preoperative exercise program before spinal surgery

Preparing the Body Before Surgery: How Prehabilitation Transforms Spinal Fusion Outcomes

By
Prof. Giorgi Pkhakadze
20/07/2026
Rick Pazdur speaking at ASCO 2026 conference about FDA restructuring and regulatory competition

FDA Leadership Signals Major Restructuring Push Amid Global Regulatory Competition

By
Prof. Giorgi Pkhakadze
16/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up